In Minnesota, biomedical companies PetVivo Holdings Inc. and Gel-Del Technologies Inc. have merged in a reverse triangular merger, meaning PetVivo created a subsidiary to buy out Gel-Del. PetVivo focuses on veterinary medical devices and partnered back in 2014 with Gel-Del to create a biomedical device similar to cartilage for dogs and horses who have osteoarthritis, which affects around 20 million dogs in Europe and the U.S. alone. Gel-Del focuses on thermoplastic biomaterials similar to human tissue and through their initial 2014 partnership, the two companies decided to merge. The merger is expected to close in April. PetVivo said it has potential human applications coming soon, so stay tuned.
Latest article
Fishway hooks Multus to jointly accelerate cultivated fish
In the United Kingdom, Fishway and Multus Biotechnology have partnered to bring cultivated fish to market faster.
The pact will leverage Fishway's expertise in...
Pirelli unveils biobased tires for Range Rovers
In Milan, tire manufacturer Pirelli has launched the first standard production tire for the global market made with over 70% biobased and recycled materials,...
MIT students design 3D printer that converts home food waste into knick-knacks
In Boston, Massachusetts Institute of Technology students Biru Cao and Qiqing Wang have developed an AI-drive desktop 3D printer that converts household food waste...